PHI with Congenital Muscular Dystrophy
How does this condition affect your private health insurance?
Congenital Muscular Dystrophy (CMD) is a diverse group of inherited muscle disorders evident at or near birth. Characterized by muscle weakness, hypotonia, and contractures, its severity varies greatly with the specific genetic mutation. Symptoms often include feeding difficulties, respiratory issues, and significant motor developmental delays. Some forms involve the brain or eyes. Management primarily involves supportive care, including physical and occupational therapy, to maintain function and manage complications, as there is currently no cure. The progressive nature frequently leads to substantial disability and reduced life expectancy in more severe cases.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Onset at birth; continuous and progressive
Duration of Illness (Lifetime)
Chronic, progressive, and lifelong
Cost of Treatment (Initial)
High (diagnostic tests, initial therapies, rehabilitation, genetic counseling)
Cost of Treatment (Lifetime)
Very high (ongoing therapies, assistive devices, medical management, specialized care)
Mortality Rate
Variable, ranging from low in milder forms to high in severe forms, often due to respiratory or cardiac complications
Risk of Secondary Damages
Very high (e.g., joint contractures, scoliosis, respiratory failure, feeding difficulties, cognitive impairment in some types)
Probability of Full Recovery
Extremely low (no known cure; management focuses on symptom control and supportive care)
Underlying Disease Risk
Moderate to high, depending on the specific genetic subtype; some forms are associated with brain malformations, ocular defects, or other systemic involvement